Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia-Reference-Cited by-同舟云学术

Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia

Published:2020-10-26 Issue:3 Volume:62 Page:696-702
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Freyer Craig W.¹^ORCID,Peterson Chelsea E.²³,Man Yun⁴,Przespolewski Amanda²^ORCID,Baron Jeffrey⁴,Luger Selina M.⁵

Affiliation:

1. Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

2. Department of Medicine, Leukemia Section. Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

3. Department of Medicine, Allegheny Health Network, Pittsburgh, PA, USA

4. Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

5. Department of Medicine, Hematology-Oncology Section, Perelman School of Medicine and the Hospital of the University of Pennsylvania, Philadelphia, PA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1838507

Reference36 articles.

1. Herpes zoster risk after 21 specific cancers: population-based case–control study

2. Herpes Zoster

3. Clinical and Subclinical Reactivations of Varicella-Zoster Virus in Immunocompromised Patients

4. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study

5. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group;Annals of Hematology;2024-08-08

2. Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy;Cancers;2024-03-15

3. Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date;Archives of Pharmacal Research;2023-12-26

4. Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus;Annals of Hematology;2022-01-07

5. Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis;Leukemia Research Reports;2022